These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 10353864

  • 1. Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy.
    Pontesilli O, Kerkhof-Garde S, Notermans DW, Foudraine NA, Roos MT, Klein MR, Danner SA, Lange JM, Miedema F.
    J Infect Dis; 1999 Jul; 180(1):76-86. PubMed ID: 10353864
    [Abstract] [Full Text] [Related]

  • 2. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
    Gray CM, Lawrence J, Schapiro JM, Altman JD, Winters MA, Crompton M, Loi M, Kundu SK, Davis MM, Merigan TC.
    J Immunol; 1999 Feb 01; 162(3):1780-8. PubMed ID: 9973442
    [Abstract] [Full Text] [Related]

  • 3. The CD160+ CD8high cytotoxic T cell subset correlates with response to HAART in HIV-1+ patients.
    Nikolova MH, Muhtarova MN, Taskov HB, Kostov K, Vezenkov L, Mihova A, Boumsell L, Bensussan A.
    Cell Immunol; 2005 Oct 01; 237(2):96-105. PubMed ID: 16337931
    [Abstract] [Full Text] [Related]

  • 4. Strong human immunodeficiency virus (HIV)-specific CD4+ T cell responses in a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy.
    Haslett PA, Nixon DF, Shen Z, Larsson M, Cox WI, Manandhar R, Donahoe SM, Kaplan G.
    J Infect Dis; 2000 Apr 01; 181(4):1264-72. PubMed ID: 10751137
    [Abstract] [Full Text] [Related]

  • 5. Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses.
    Ostrowski MA, Gu JX, Kovacs C, Freedman J, Luscher MA, MacDonald KS.
    J Infect Dis; 2001 Nov 15; 184(10):1268-78. PubMed ID: 11679915
    [Abstract] [Full Text] [Related]

  • 6. Characteristics of HIV-1-specific CD8 T-cell responses and their role in loss of viremia in children chronically infected with HIV-1 undergoing highly active antiretroviral therapy.
    Zhang Z, Zhao QX, Fu JL, Yao JX, He Y, Jin L, Wang FS.
    Chin Med J (Engl); 2006 Dec 05; 119(23):1949-57. PubMed ID: 17199938
    [Abstract] [Full Text] [Related]

  • 7. Effect of HIV infection and antiretroviral therapy on hepatitis B virus (HBV)-specific T cell responses in patients who have resolved HBV infection.
    Lascar RM, Lopes AR, Gilson RJ, Dunn C, Johnstone R, Copas A, Reignat S, Webster G, Bertoletti A, Maini MK.
    J Infect Dis; 2005 Apr 01; 191(7):1169-79. PubMed ID: 15747254
    [Abstract] [Full Text] [Related]

  • 8. Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution.
    Blankson JN, Gallant JE, Siliciano RF.
    J Infect Dis; 2001 Feb 15; 183(4):657-61. PubMed ID: 11170994
    [Abstract] [Full Text] [Related]

  • 9. Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy.
    Valor L, Navarro J, Carbone J, Rodríguez-Sáinz C, Gil J, López F, Fernández-Cruz E, STIR-2102 Team.
    Vaccine; 2008 May 23; 26(22):2738-45. PubMed ID: 18433946
    [Abstract] [Full Text] [Related]

  • 10. Long-term highly active antiretroviral therapy in chronic HIV-1 infection: evidence for reconstitution of antiviral immunity.
    Jansen CA, Piriou E, De Cuyper IM, van Dort K, Lange JM, Miedema F, van Baarle D.
    Antivir Ther; 2006 May 23; 11(1):105-16. PubMed ID: 16518966
    [Abstract] [Full Text] [Related]

  • 11. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
    López M, Soriano V, Rallón N, Cascajero A, González-Lahoz J, Benito JM.
    Eur J Immunol; 2008 Jun 23; 38(6):1548-58. PubMed ID: 18421792
    [Abstract] [Full Text] [Related]

  • 12. Persistant immunodominant anti-gag SLYNTVATL responses in HIV-patients with up to 7 years of HAART.
    Zidovec Lepej S, Kosor E, Gagro A, Vince A, Remenar A, Poljak M.
    Coll Antropol; 2006 Dec 23; 30 Suppl 2():33-8. PubMed ID: 17508471
    [Abstract] [Full Text] [Related]

  • 13. Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.
    Ostrowski SR, Katzenstein TL, Pedersen BK, Gerstoft J, Ullum H.
    Scand J Immunol; 2008 Dec 23; 68(6):652-60. PubMed ID: 19055701
    [Abstract] [Full Text] [Related]

  • 14. Antimicrobial-specific cell-mediated immune reconstitution in children with advanced human immunodeficiency virus infection receiving highly active antiretroviral therapy.
    Weinberg A, Pahwa S, Oyomopito R, Carey VJ, Zimmer B, Mofenson L, Kovacs A, Burchett SK, Pediatric AIDS Clinical Trials Group 366 Team.
    Clin Infect Dis; 2004 Jul 01; 39(1):107-14. PubMed ID: 15206061
    [Abstract] [Full Text] [Related]

  • 15. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
    Benito JM, López M, Lozano S, González-Lahoz J, Soriano V.
    J Infect Dis; 2008 Nov 15; 198(10):1466-73. PubMed ID: 18847371
    [Abstract] [Full Text] [Related]

  • 16. Assessment of human cytomegalovirus specific T cell immunity in human immunodeficiency virus infected patients in different disease stages following HAART and in long-term non-progressors.
    Tamarit A, Alberola J, Mira JV, Tornero C, Galindo MJ, Navarro D.
    J Med Virol; 2004 Nov 15; 74(3):382-9. PubMed ID: 15368523
    [Abstract] [Full Text] [Related]

  • 17. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy.
    Keane NM, Price P, Lee S, Almeida CA, Stone SF, James I, French MA.
    HIV Med; 2004 Nov 15; 5(6):407-14. PubMed ID: 15544692
    [Abstract] [Full Text] [Related]

  • 18. Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.
    Oxenius A, Price DA, Günthard HF, Dawson SJ, Fagard C, Perrin L, Fischer M, Weber R, Plana M, García F, Hirschel B, McLean A, Phillips RE.
    Proc Natl Acad Sci U S A; 2002 Oct 15; 99(21):13747-52. PubMed ID: 12370434
    [Abstract] [Full Text] [Related]

  • 19. The relationship between T cell proliferative responses and plasma viremia during treatment of human immunodeficiency virus type 1 infection with combination antiretroviral therapy.
    Binley JM, Schiller DS, Ortiz GM, Hurley A, Nixon DF, Markowitz MM, Moore JP.
    J Infect Dis; 2000 Apr 15; 181(4):1249-63. PubMed ID: 10762561
    [Abstract] [Full Text] [Related]

  • 20. Inverse correlation between memory Gag-specific cytotoxic T lymphocytes and viral replication in human immunodeficiency virus-infected children.
    Buseyne F, Le Chenadec J, Corre B, Porrot F, Burgard M, Rouzioux C, Blanche S, Mayaux MJ, Rivière Y.
    J Infect Dis; 2002 Dec 01; 186(11):1589-96. PubMed ID: 12447734
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.